secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001193125-25-319441
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics raises ~$1.7M in registered direct offering at $0.33/share with warrants
--------------------------------------------------------------------------------

- Sold 5,227,275 shares at $0.33/share; gross proceeds ~$1.7M; closing expected Dec 16, 2025.
- Concurrent private placement of warrants to buy 5,227,275 shares at $0.33, exercisable only after stockholder approval, 5-year term.
- CEO and prior purchaser entered voting agreements to support warrant share issuance under Nasdaq rules.
- Placement agent H.C. Wainwright receives 7% cash fee and 365,909 warrants at $0.4125 per share.
- Net proceeds for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312525319441/0001193125-25-319441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312525319441/fblg-20251214.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-319441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer